CURTANA PHARMACEUTICALS INC
Biotech · Private
Small-molecule CNS-penetrant inhibitors of casein kinase II for glioblastoma treatment
curtanapharma.com →- Grants
- $600K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 18
- 5 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Discovery of Novel Therapeutics for Glioblastoma | $300,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Discovery of Novel Therapeutics for Glioblastoma | $300,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1662 | OGB5, INC. | — | — |
| 1663 | CHEMEDIMMUNE, INC. | — | — |
| 1664 | KXT BIO INC. | — | — |
| 1665 | CURTANA PHARMACEUTICALS INC | — | — |
| 1666 | Pathfinder Therapeutics, Inc. | — | $9.6M |
| 1667 | CURIO BIOSCIENCE INC. | — | — |
| 1668 | ATHNA BIOTECH INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Inhibition Of OLIG2 Activitygranted
- Combination Therapies With OLIG2 Inhibitorsapplication
- Inhibition Of OLIG2 Activityapplication
- Inhibition Of OLIG2 Activitygranted
- Inhibition Of OLIG2 Activitygranted
- Inhibition Of OLIG2 Activitygranted
- Inhibition Of OLIG2 Activityapplication
- Inhibition Of OLIG2 Activitygranted
- Inhibition Of OLIG2 Activityapplication
- Combination Therapies With OLIG2 Inhibitorsapplication
- Inhibition Of OLIG2 Activityapplication
- Inhibition Of OLIG2 Activityapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.